Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-043316
Filing Date
2022-04-06
Accepted
2022-04-06 18:20:25
Documents
1
Period of Report
2022-04-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2211710-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2211710-2_4seq1.xml 4 10298
  Complete submission text file 0001104659-22-043316.txt   11741
Mailing Address C/O AKEBIA THERAPEUTICS, INC. 245 FIRST STREET, SUITE 1100 CAMBRIDGE MA 02142
Business Address
Nielsen Jack (Reporting) CIK: 0001602402 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39450 | Film No.: 22811670

Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Issuer) CIK: 0001802665 (see all company filings)

EIN.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations